Inverna Therapeutics

Inverna Therapeutics is a cutting-edge biotechnology research company focused on developing transformative RNA therapeutics through precision RNA splicing modulation. Leveraging a proprietary drug discovery platform, Inverna Therapeutics is dedicated to designing, testing, and developing highly specific activators of pseudo-exons in disease-relevant target RNA.

Located at Campusvej 55, Odense, Denmark, 5230, DK, Inverna Therapeutics operates with a commitment to innovation and excellence in the field of RNA therapeutics. The company's unique technology promises to revolutionize the treatment of various diseases by targeting RNA splicing with unprecedented precision.

Inverna Therapeutics is poised to make significant contributions to the biotechnology landscape, driving advancements in precision medicine and improving patient outcomes. We encourage the management team at Inverna Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.